Orit Twito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Orit Twito has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Chava Rosenblum
Endocrinology and Diabetes Unit, Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Holon 58100, Israel
6 shared publications - Daniela Jakubowicz
Endocrinology and Diabetes Unit, Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Holon 58100, Israel
4 shared publications - Haggi Mazeh
Department of Surgery, Hadassah Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel
4 shared publications Dan Nabriski
3 shared publications- Dania Hirsch
Institute of Endocrinology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
3 shared publications - David J. Gross
Neuroendocrine Tumor Unit, Endocrinology & Metabolism Service, Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
3 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (11) , bvag237
Age-dependent impact of diabetes on limb events and mortality in patients with peripheral artery disease
Background: Peripheral artery disease (PAD) is associated with substantial risks of limb events and mortality. Although diabetes is a recognized risk factor for adverse outcomes in PAD, its prognostic impact across different ages at PAD onset remains unclear. Methods: In this retrospective population-based cohort study, adults with PAD were identified from Clalit Health Services, Israel (2000-2026). Patients were stratified by diabetes status and age at PAD diagnosis (35-50 vs > 50 years). The primary outcome was major adverse limb events (MALE), defined as lower-extremity revascularization or major amputation. All-cause mortality was a secondary outcome. Multivariable Cox regression, interaction analyses, and propensity score overlap weighting were performed. Results: Among 4538 patients aged 35-50 years at PAD diagnosis, 1902 (42%) had diabetes. During a median follow-up of 12.0 years, diabetes was independently associated with higher risks of MALE (hazard ratio [HR] 1.44, 95% confidence interval [CI] 1.03-2.01, P = .032) and mortality (HR 1.41, 95% CI 1.18-1.70, P < .001). Diabetes was associated with increased MALE risk in both age groups, with no significant interaction by age (P for interaction = .498). In contrast, the association between diabetes and mortality was significantly stronger in patients aged 35-50 years than in those aged >50 years (adjusted HR 2.00, 95% CI 1.72-2.33 vs 1.30, 95% CI 1.27-1.33, P for interaction < .001). Excess mortality associated with diabetes emerged during longer-term follow-up. Conclusion: Diabetes was associated with increased risks of MALE and mortality in PAD, with a stronger association with mortality among patients diagnosed before age 50. These findings identify diabetes as a marker of particularly high risk in premature PAD.
- 5 October 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (11) , bvag237
Open AccessAge-dependent impact of diabetes on limb events and mortality in patients with peripheral artery disease
Background: Peripheral artery disease (PAD) is associated with substantial risks of limb events and mortality. Although diabetes is a recognized risk factor for adverse outcomes in PAD, its prognostic impact across different ages at PAD onset remains unclear. Methods: In this retrospective population-based cohort study, adults with PAD were identified from Clalit Health Services, Israel (2000-2026). Patients were stratified by diabetes status and age at PAD diagnosis (35-50 vs > 50 years). The primary outcome was major adverse limb events (MALE), defined as lower-extremity revascularization or major amputation. All-cause mortality was a secondary outcome. Multivariable Cox regression, interaction analyses, and propensity score overlap weighting were performed. Results: Among 4538 patients aged 35-50 years at PAD diagnosis, 1902 (42%) had diabetes. During a median follow-up of 12.0 years, diabetes was independently associated with higher risks of MALE (hazard ratio [HR] 1.44, 95% confidence interval [CI] 1.03-2.01, P = .032) and mortality (HR 1.41, 95% CI 1.18-1.70, P < .001). Diabetes was associated with increased MALE risk in both age groups, with no significant interaction by age (P for interaction = .498). In contrast, the association between diabetes and mortality was significantly stronger in patients aged 35-50 years than in those aged >50 years (adjusted HR 2.00, 95% CI 1.72-2.33 vs 1.30, 95% CI 1.27-1.33, P for interaction < .001). Excess mortality associated with diabetes emerged during longer-term follow-up. Conclusion: Diabetes was associated with increased risks of MALE and mortality in PAD, with a stronger association with mortality among patients diagnosed before age 50. These findings identify diabetes as a marker of particularly high risk in premature PAD.
- Open Access
- 17 September 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (18) , 3057
From Crisis to Care: A Multidisciplinary Care Framework for Repatriated Civilian Hostages: Development, Implementation, and Early Outcomes
Objective: On 7 October 2023, Hamas-led militants attacked Israeli communities bordering the Gaza Strip, abducting 251 people, including 201 civilians. Wolfson Medical Center was chosen by Israel’s Ministry of Health to care for repatriated civilians following a hostage release deal. We describe the development and implementation of a multidisciplinary care framework and report the clinical characteristics and short-term hospital outcomes of the repatriated civilians treated within it. Methods: A multidisciplinary framework was developed and implemented to address acute and chronic medical conditions, physical trauma, sexual assault, psychosocial support, and nutritional rehabilitation. Clinical characteristics and short-term hospital outcomes were retrospectively extracted from the electronic medical records. Results: Between 24 November and 1 December 2023, we treated 10 repatriated female hostages (median age 67 years, range 29–85 years) held captive for 48–55 days. They suffered physical trauma and loss of family members during the 7 October events. Captivity was associated with inadequate nutrition, poor hygiene, physical injuries, psychological distress, and insufficient management of chronic medical conditions. Acute conditions on arrival included rapid atrial fibrillation, heart failure, deep vein thrombosis, endocrine abnormalities, gastrointestinal symptoms and dermatologic conditions. Care required individualized planning, flexibility, and close coordination with national authorities, community health providers, and social services. Conclusions: Our experience highlights the need for comprehensive, coordinated care frameworks that not only address the medical, psychological, and social complexities of early recovery and reintegration but also ensure effective oversight and training of the medical teams involved.
- 17 September 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (18) , 3057
Open AccessFrom Crisis to Care: A Multidisciplinary Care Framework for Repatriated Civilian Hostages: Development, Implementation, and Early Outcomes
Objective: On 7 October 2023, Hamas-led militants attacked Israeli communities bordering the Gaza Strip, abducting 251 people, including 201 civilians. Wolfson Medical Center was chosen by Israel’s Ministry of Health to care for repatriated civilians following a hostage release deal. We describe the development and implementation of a multidisciplinary care framework and report the clinical characteristics and short-term hospital outcomes of the repatriated civilians treated within it. Methods: A multidisciplinary framework was developed and implemented to address acute and chronic medical conditions, physical trauma, sexual assault, psychosocial support, and nutritional rehabilitation. Clinical characteristics and short-term hospital outcomes were retrospectively extracted from the electronic medical records. Results: Between 24 November and 1 December 2023, we treated 10 repatriated female hostages (median age 67 years, range 29–85 years) held captive for 48–55 days. They suffered physical trauma and loss of family members during the 7 October events. Captivity was associated with inadequate nutrition, poor hygiene, physical injuries, psychological distress, and insufficient management of chronic medical conditions. Acute conditions on arrival included rapid atrial fibrillation, heart failure, deep vein thrombosis, endocrine abnormalities, gastrointestinal symptoms and dermatologic conditions. Care required individualized planning, flexibility, and close coordination with national authorities, community health providers, and social services. Conclusions: Our experience highlights the need for comprehensive, coordinated care frameworks that not only address the medical, psychological, and social complexities of early recovery and reintegration but also ensure effective oversight and training of the medical teams involved.
- Open Access
- 1 August 2026
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 10 (8)
25-Hydroxyvitamin D Levels, Free Serum Calcium, Glomerular Filtration Rate, Albumin, and Femoral Fracture Elderly Patient Mortality
Introduction: Proximal femoral fractures (PFFs) in older adults carry a high risk of morbidity, mortality, and disability. Although vitamin D deficiency has been associated with increased fracture incidence and poor outcomes, its precise role in hospitalization length, mortality, and long-term recovery remains unclear. Understanding how vitamin D levels interact with other factors, such as renal function and albumin status, could improve patient management strategies. Methods: We conducted a prospective cohort study of 760 patients aged 65 years and older admitted with femoral fractures between November 2022 and October 2024. Serum 25(OH)D levels, corrected calcium, and glomerular filtration rate (GFR) were assessed at admission. Vitamin D status was categorized as deficient (30 ng/mL). Albumin levels and GFR were also evaluated. Results: When analyzed categorically, vitamin D classification did not markedly predict short-term outcomes, including immediate postoperative mortality or length of hospital stay. However, vitamin D as a continuous variable was modestly associated with shorter hospital stays. By contrast, lower GFR was strongly linked to longer hospitalization and increased in-hospital mortality. Albumin levels were not markedly related to survival. Notably, over a 2-year follow-up, vitamin D status emerged as an important predictor of long-term survival. Conclusion: Although vitamin D status alone may not influence immediate recovery, maintaining adequate levels may improve longer term survival after PFF surgery. Addressing renal impairment and other patient-specific factors remains critical for optimizing outcomes.
- 1 August 2026
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 10 (8)
Open Access25-Hydroxyvitamin D Levels, Free Serum Calcium, Glomerular Filtration Rate, Albumin, and Femoral Fracture Elderly Patient Mortality
Introduction: Proximal femoral fractures (PFFs) in older adults carry a high risk of morbidity, mortality, and disability. Although vitamin D deficiency has been associated with increased fracture incidence and poor outcomes, its precise role in hospitalization length, mortality, and long-term recovery remains unclear. Understanding how vitamin D levels interact with other factors, such as renal function and albumin status, could improve patient management strategies. Methods: We conducted a prospective cohort study of 760 patients aged 65 years and older admitted with femoral fractures between November 2022 and October 2024. Serum 25(OH)D levels, corrected calcium, and glomerular filtration rate (GFR) were assessed at admission. Vitamin D status was categorized as deficient (30 ng/mL). Albumin levels and GFR were also evaluated. Results: When analyzed categorically, vitamin D classification did not markedly predict short-term outcomes, including immediate postoperative mortality or length of hospital stay. However, vitamin D as a continuous variable was modestly associated with shorter hospital stays. By contrast, lower GFR was strongly linked to longer hospitalization and increased in-hospital mortality. Albumin levels were not markedly related to survival. Notably, over a 2-year follow-up, vitamin D status emerged as an important predictor of long-term survival. Conclusion: Although vitamin D status alone may not influence immediate recovery, maintaining adequate levels may improve longer term survival after PFF surgery. Addressing renal impairment and other patient-specific factors remains critical for optimizing outcomes.
- Open Access
- 9 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Impact of a Diabetes Nurse Practitioner–Led Surveillance Program on the Severity of Inpatient Hypoglycemia: A Retrospective Cohort Study (Preprint)
BACKGROUND Inpatient hypoglycemia remains a common and potentially preventable adverse event among hospitalized patients with diabetes mellitus (DM). Severe hypoglycemia is associated with increased morbidity, mortality, prolonged hospitalization, and healthcare costs. Continuous surveillance programs led by DM nurse practitioners may improve early detection and management of hypoglycemic events OBJECTIVE To evaluate the impact of a DM nurse practitioner-led surveillance program on the severity and clinical characteristics of inpatient hypoglycemia. METHODS This retrospective cohort study was conducted at a tertiary medical center and included hospitalized adults with DM who experienced hypoglycemia during three study periods: pre-intervention (September-December 2022) and two post-intervention periods (September-December 2023 and September-December 2024). Beginning in January 2023, DM nurse practitioners conducted daily computerized surveillance of hypoglycemic events, followed by individualized case reviews, treatment recommendations, staff education, patient counseling, and follow-up. Hypoglycemia was defined as blood glucose <70 mg/dL and severe hypoglycemia as <54 mg/dL. Multivariable logistic regression was performed to identify independent predictors of severe hypoglycemia. RESULTS A total of 721 hospitalizations of patients with DM and hypoglycemic event were analyzed (147 in 2022, 290 in 2023, and 284 in 2024). Following implementation of the surveillance program, the observed rate of hypoglycemic events increased from 7.4 to 14.5 events per 100 hospitalized patients with DM. Despite this increase, hypoglycemia severity decreased substantially over time. The proportion of severe hypoglycemia (<54 mg/dL) declined from 31.3% in 2022 to 25.2% in 2023 and 11.6% in 2024 (P<0.001). Similar reductions were observed across progressively lower glucose thresholds, with profound hypoglycemia (<40 mg/dL) decreasing from 17.7% to 4.6% (P<0.001). Significant reductions in severe hypoglycemia were observed during both morning shifts (29.3% to 9.5%, P<0.001) and evening shifts (35.6% to 14.8%, P<0.001), as well as during weekdays and weekends. In multivariable analysis, the 2024 study period remained independently associated with a lower likelihood of severe hypoglycemia compared with 2022 (adjusted OR 0.28, 95% CI 0.17–0.47; P<0.001), corresponding to a 72% relative reduction in the odds of severe hypoglycemia. Evening-shift events were independently associated with increased risk of severe hypoglycemia (adjusted OR 2.15, 95% CI 1.39–3.31; P<0.001). CONCLUSIONS Implementation of a DM nurse practitioner–led surveillance program was associated with a marked and sustained reduction in the severity of inpatient hypoglycemia despite increased detection of hypoglycemic events. These findings suggest that proactive nurse-led surveillance may improve inpatient glycemic safety and facilitate earlier identification and intervention before progression to severe hypoglycemia.
- 9 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImpact of a Diabetes Nurse Practitioner–Led Surveillance Program on the Severity of Inpatient Hypoglycemia: A Retrospective Cohort Study (Preprint)
BACKGROUND Inpatient hypoglycemia remains a common and potentially preventable adverse event among hospitalized patients with diabetes mellitus (DM). Severe hypoglycemia is associated with increased morbidity, mortality, prolonged hospitalization, and healthcare costs. Continuous surveillance programs led by DM nurse practitioners may improve early detection and management of hypoglycemic events OBJECTIVE To evaluate the impact of a DM nurse practitioner-led surveillance program on the severity and clinical characteristics of inpatient hypoglycemia. METHODS This retrospective cohort study was conducted at a tertiary medical center and included hospitalized adults with DM who experienced hypoglycemia during three study periods: pre-intervention (September-December 2022) and two post-intervention periods (September-December 2023 and September-December 2024). Beginning in January 2023, DM nurse practitioners conducted daily computerized surveillance of hypoglycemic events, followed by individualized case reviews, treatment recommendations, staff education, patient counseling, and follow-up. Hypoglycemia was defined as blood glucose <70 mg/dL and severe hypoglycemia as <54 mg/dL. Multivariable logistic regression was performed to identify independent predictors of severe hypoglycemia. RESULTS A total of 721 hospitalizations of patients with DM and hypoglycemic event were analyzed (147 in 2022, 290 in 2023, and 284 in 2024). Following implementation of the surveillance program, the observed rate of hypoglycemic events increased from 7.4 to 14.5 events per 100 hospitalized patients with DM. Despite this increase, hypoglycemia severity decreased substantially over time. The proportion of severe hypoglycemia (<54 mg/dL) declined from 31.3% in 2022 to 25.2% in 2023 and 11.6% in 2024 (P<0.001). Similar reductions were observed across progressively lower glucose thresholds, with profound hypoglycemia (<40 mg/dL) decreasing from 17.7% to 4.6% (P<0.001). Significant reductions in severe hypoglycemia were observed during both morning shifts (29.3% to 9.5%, P<0.001) and evening shifts (35.6% to 14.8%, P<0.001), as well as during weekdays and weekends. In multivariable analysis, the 2024 study period remained independently associated with a lower likelihood of severe hypoglycemia compared with 2022 (adjusted OR 0.28, 95% CI 0.17–0.47; P<0.001), corresponding to a 72% relative reduction in the odds of severe hypoglycemia. Evening-shift events were independently associated with increased risk of severe hypoglycemia (adjusted OR 2.15, 95% CI 1.39–3.31; P<0.001). CONCLUSIONS Implementation of a DM nurse practitioner–led surveillance program was associated with a marked and sustained reduction in the severity of inpatient hypoglycemia despite increased detection of hypoglycemic events. These findings suggest that proactive nurse-led surveillance may improve inpatient glycemic safety and facilitate earlier identification and intervention before progression to severe hypoglycemia.
- Open Access
- 19 March 2026
- Published by Springer Nature in Hormones
- Vol. 25 (2) , 365-375
RET Lys666Asn has a low rate of MEN2-related tumors but may be associated with pheochromocytoma
Purpose: Multiple endocrine neoplasia type 2 (MEN2) is caused by germline pathogenic variants (PVs) in the RET proto-oncogene, leading to medullary thyroid carcinoma (MTC), pheochromocytoma, and primary hyperparathyroidism (PHPT). RET p.Lys666Asn is a rare PV, but its clinical significance remains incompletely understood. The purpose of this study is to expand the clinical understanding of the RET Lys666Asn variant. Methods: Index patients carrying the RET Lys666Asn variant were identified through clinical genetic testing in two referral medical centers. Comprehensive clinical evaluation, biochemical screening, and imaging studies were performed to assess the presence of MTC, pheochromocytoma, and PHPT of the index patients and carrier family members. We performed a literature search on Lys666Asn carriers and their clinical manifestations. Results: Ten individuals from five families were identified as carriers of the RET Lys666Asn variant. The median age at diagnosis was 43.7 years (range 2–75 years). Only one individual presented with pheochromocytoma, diagnosed at age 54. The rate of MTC, pheochromocytoma, and PHPT was 0 (0–0.26), 0.1 (0.01–0.39), and 0 (0–0.26), respectively. In a pooled analysis of cases reported in the literature, MTC, pheochromocytoma, and PHPT rate are 0.42 (0.28–0.57), 0.11 (0.04–0.22), and 0.03 (0–0.12), respectively. MTC had a wide age range at presentation (20–70 years). Conclusion: The RET Lys666Asn variant is associated with lower event rate of MEN2-related tumors compared to classical MEN2 variants, particularly MTC and pheochromocytoma. Despite its rarity, pheochromocytoma cannot be excluded in carriers, underscoring the need for individualized screening protocols based on specific RET variants.
- 19 March 2026
- Published by Springer Nature in Hormones
- Vol. 25 (2) , 365-375
Open AccessRET Lys666Asn has a low rate of MEN2-related tumors but may be associated with pheochromocytoma
Purpose: Multiple endocrine neoplasia type 2 (MEN2) is caused by germline pathogenic variants (PVs) in the RET proto-oncogene, leading to medullary thyroid carcinoma (MTC), pheochromocytoma, and primary hyperparathyroidism (PHPT). RET p.Lys666Asn is a rare PV, but its clinical significance remains incompletely understood. The purpose of this study is to expand the clinical understanding of the RET Lys666Asn variant. Methods: Index patients carrying the RET Lys666Asn variant were identified through clinical genetic testing in two referral medical centers. Comprehensive clinical evaluation, biochemical screening, and imaging studies were performed to assess the presence of MTC, pheochromocytoma, and PHPT of the index patients and carrier family members. We performed a literature search on Lys666Asn carriers and their clinical manifestations. Results: Ten individuals from five families were identified as carriers of the RET Lys666Asn variant. The median age at diagnosis was 43.7 years (range 2–75 years). Only one individual presented with pheochromocytoma, diagnosed at age 54. The rate of MTC, pheochromocytoma, and PHPT was 0 (0–0.26), 0.1 (0.01–0.39), and 0 (0–0.26), respectively. In a pooled analysis of cases reported in the literature, MTC, pheochromocytoma, and PHPT rate are 0.42 (0.28–0.57), 0.11 (0.04–0.22), and 0.03 (0–0.12), respectively. MTC had a wide age range at presentation (20–70 years). Conclusion: The RET Lys666Asn variant is associated with lower event rate of MEN2-related tumors compared to classical MEN2 variants, particularly MTC and pheochromocytoma. Despite its rarity, pheochromocytoma cannot be excluded in carriers, underscoring the need for individualized screening protocols based on specific RET variants.
- Open Access
- 23 January 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (4) , 1021-1034
Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial
Aims/hypothesis: The circadian timing of food intake and the composition of dietary protein sources may jointly influence metabolic regulation. Our aim was to examine the effects of a dairy-enriched vs non-dairy isoenergetic diet with structured meal timing on circadian clock gene expression, glycaemic management and appetite regulation in individuals with type 2 diabetes. Methods: In a randomised, crossover trial, 25 participants with type 2 diabetes and HbA 1c ≥48 mmol/mol (6.5%), treated either with stable doses (≥3 months) of oral glucose-lowering agents or managed by diet, followed two 4 week dietary phases, one including dairy-based protein sources (YesMilk) and one excluding them (NoMilk), with a 3–4 week washout. Participants were randomly assigned to one of two intervention sequences using simple randomisation (coin flip), either starting with the YesMilk diet followed by the NoMilk diet, or vice versa. Due to the open-label design, allocation was not concealed from investigators or participants. The study was powered for the primary outcome of circadian clock gene expression in peripheral blood mononuclear cells. Secondary outcomes included glycaemic indices derived from continuous glucose monitoring (CGM) and appetite scores. The study was conducted via the Diabetes Unit at Wolfson Medical Center, Israel. Results: Twenty-nine individuals were screened; 25 met eligibility criteria and were randomised to YesMilk or NoMilk dietary interventions in a crossover design. Thirteen participants began with the YesMilk dairy diet, all of whom completed both phases. Of the 12 who began with the NoMilk diet, six completed the study. Nineteen participants completed both intervention phases. Compared with the NoMilk phase, the YesMilk diet upregulated BMAL1 (+1.8-fold, p =0.0003), REV-ERBα (also known as NRD1D1 ) (+2.2-fold, p CRY1 (+1.4-fold, p =0.03), with higher PER1 expression ( p =0.01 between diets at 4 weeks). Glycaemic variables improved under the YesMilk diet, with fasting glucose reduced by ~1.7 mmol/l, glucose management indicator reduced by 0.7%, and time in range increased by 9% compared with baseline (all p p <0.05). Conclusions/interpretation: A dairy-enriched diet aligned with structured meal timing enhanced circadian clock gene expression and improved glycaemic and appetite-related variables in individuals with type 2 diabetes. These findings support a mechanistic link between dietary protein source, circadian regulation and metabolic health, warranting confirmation in larger, long-term studies. Trial registration: ClincalTrials.gov NCT03772067 Funding: The Israeli Ministry of Health provided funding. Graphical
- 23 January 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (4) , 1021-1034
Open AccessGlycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial
Aims/hypothesis: The circadian timing of food intake and the composition of dietary protein sources may jointly influence metabolic regulation. Our aim was to examine the effects of a dairy-enriched vs non-dairy isoenergetic diet with structured meal timing on circadian clock gene expression, glycaemic management and appetite regulation in individuals with type 2 diabetes. Methods: In a randomised, crossover trial, 25 participants with type 2 diabetes and HbA 1c ≥48 mmol/mol (6.5%), treated either with stable doses (≥3 months) of oral glucose-lowering agents or managed by diet, followed two 4 week dietary phases, one including dairy-based protein sources (YesMilk) and one excluding them (NoMilk), with a 3–4 week washout. Participants were randomly assigned to one of two intervention sequences using simple randomisation (coin flip), either starting with the YesMilk diet followed by the NoMilk diet, or vice versa. Due to the open-label design, allocation was not concealed from investigators or participants. The study was powered for the primary outcome of circadian clock gene expression in peripheral blood mononuclear cells. Secondary outcomes included glycaemic indices derived from continuous glucose monitoring (CGM) and appetite scores. The study was conducted via the Diabetes Unit at Wolfson Medical Center, Israel. Results: Twenty-nine individuals were screened; 25 met eligibility criteria and were randomised to YesMilk or NoMilk dietary interventions in a crossover design. Thirteen participants began with the YesMilk dairy diet, all of whom completed both phases. Of the 12 who began with the NoMilk diet, six completed the study. Nineteen participants completed both intervention phases. Compared with the NoMilk phase, the YesMilk diet upregulated BMAL1 (+1.8-fold, p =0.0003), REV-ERBα (also known as NRD1D1 ) (+2.2-fold, p CRY1 (+1.4-fold, p =0.03), with higher PER1 expression ( p =0.01 between diets at 4 weeks). Glycaemic variables improved under the YesMilk diet, with fasting glucose reduced by ~1.7 mmol/l, glucose management indicator reduced by 0.7%, and time in range increased by 9% compared with baseline (all p p <0.05). Conclusions/interpretation: A dairy-enriched diet aligned with structured meal timing enhanced circadian clock gene expression and improved glycaemic and appetite-related variables in individuals with type 2 diabetes. These findings support a mechanistic link between dietary protein source, circadian regulation and metabolic health, warranting confirmation in larger, long-term studies. Trial registration: ClincalTrials.gov NCT03772067 Funding: The Israeli Ministry of Health provided funding. Graphical
- Open Access
- 6 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 7062
Efficacy of a Computerized Therapeutic Decision-Making Algorithm in a Fracture Liaison Service Targeting Hip Fracture Patients
Introduction: This study evaluates the efficacy of a nurse practitioner-managed, computer algorithm-supported institutional fracture liaison service (FLS) that provides treatment recommendations for patients with hip fractures. Methods: A retrospective study included patients hospitalized in the Orthopedic ward with hip fractures between April 1 and October 31. The decision-making algorithm recommends zoledronic acid as the default medication, except for patients younger than 65 years, with estimated glomerular filtration rate (eGFR) <35 or prior osteoporosis therapy, who are ordered to undergo endocrinology consultation. Patients with vitamin D deficiency/insufficiency are given a loading dose. Results: Two hundred and eight hip fracture patients were identified. The cohort was predominantly female (137/208, 65.9%); the mean age was 79.9 ± 9.6 years. Nurse practitioner evaluation was performed in 200/208 patients (96.2%). The algorithm provided a treatment recommendation in 140 out of 200 (70.0%), while 60 out of 200 (30.0%) required an endocrinology consultation. A Vitamin D loading dose was given in 89/99 (89.9%) deficiency and 44/62 (71.0%) insufficiency cases. Conclusions: This simplified algorithm-based FLS model demonstrated practicality and feasibility in providing therapeutic recommendations with minimal physician intervention.
- 6 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 7062
Open AccessEfficacy of a Computerized Therapeutic Decision-Making Algorithm in a Fracture Liaison Service Targeting Hip Fracture Patients
Introduction: This study evaluates the efficacy of a nurse practitioner-managed, computer algorithm-supported institutional fracture liaison service (FLS) that provides treatment recommendations for patients with hip fractures. Methods: A retrospective study included patients hospitalized in the Orthopedic ward with hip fractures between April 1 and October 31. The decision-making algorithm recommends zoledronic acid as the default medication, except for patients younger than 65 years, with estimated glomerular filtration rate (eGFR) <35 or prior osteoporosis therapy, who are ordered to undergo endocrinology consultation. Patients with vitamin D deficiency/insufficiency are given a loading dose. Results: Two hundred and eight hip fracture patients were identified. The cohort was predominantly female (137/208, 65.9%); the mean age was 79.9 ± 9.6 years. Nurse practitioner evaluation was performed in 200/208 patients (96.2%). The algorithm provided a treatment recommendation in 140 out of 200 (70.0%), while 60 out of 200 (30.0%) required an endocrinology consultation. A Vitamin D loading dose was given in 89/99 (89.9%) deficiency and 44/62 (71.0%) insufficiency cases. Conclusions: This simplified algorithm-based FLS model demonstrated practicality and feasibility in providing therapeutic recommendations with minimal physician intervention.
- Open Access
- 4 June 2025
- Published by Wiley in Anz Journal of Surgery
- Vol. 95 (6) , 1216-1219
Pre‐Operative Radiological Diagnosis of Appendiceal Neuroendocrine Neoplasms: Implications for Conservative Management of Acute Appendicitis
Background: Non‐surgical treatment of appendicitis carries the risk of missed tumors, such as appendiceal neuroendocrine neoplasms (ANEN), the most common appendiceal tumor. The aim of this study is to identify radiological features of ANEN that will distinguish them from simple acute appendicitis. Methods: Data were extracted from a database of 8327 appendectomies conducted during 2005–2018. Pre‐operative computerized tomography (CT) or ultrasound (US) scans of patients with ANEN and a random sample of patients with simple appendicitis were compared. Patients with other appendiceal tumors were excluded. All images were reviewed by a blinded, experienced radiologist. Results: Thirty‐five ANEN (20 CT, 15 US) were compared to 50 cases with simple appendicitis (30 CT, 20 US). Age was similar between study groups (33.8 ± 19.2 vs. 35.2 ± 17.9, respectively, p = 0.378); female gender was more prevalent in the ANEN group (65.7% vs. 38.3%, p = 0.017). ANEN size per pathology report was 17.0 ± 13.4 mm, and mesoappendix invasion was evident in 37.1%. Appendiceal diameter, regional lymph node number, and size were similar. Evidence of solid tissue in the appendiceal lumen per CT was more prevalent in the ANEN group compared to controls (7/20 [35%] vs. 2/30 [6.7%], p = 0.0008). Conclusions: Although the majority of ANEN cannot be identified in pre‐appendectomy imaging, 35% of cases demonstrate the presence of solid tissue in the appendiceal lumen. This finding may distinguish these patients from those with simple appendicitis and should lead to early surgical intervention, or close and more cautious surveillance if a conservative approach is chosen.
- 4 June 2025
- Published by Wiley in Anz Journal of Surgery
- Vol. 95 (6) , 1216-1219
Open AccessPre‐Operative Radiological Diagnosis of Appendiceal Neuroendocrine Neoplasms: Implications for Conservative Management of Acute Appendicitis
Background: Non‐surgical treatment of appendicitis carries the risk of missed tumors, such as appendiceal neuroendocrine neoplasms (ANEN), the most common appendiceal tumor. The aim of this study is to identify radiological features of ANEN that will distinguish them from simple acute appendicitis. Methods: Data were extracted from a database of 8327 appendectomies conducted during 2005–2018. Pre‐operative computerized tomography (CT) or ultrasound (US) scans of patients with ANEN and a random sample of patients with simple appendicitis were compared. Patients with other appendiceal tumors were excluded. All images were reviewed by a blinded, experienced radiologist. Results: Thirty‐five ANEN (20 CT, 15 US) were compared to 50 cases with simple appendicitis (30 CT, 20 US). Age was similar between study groups (33.8 ± 19.2 vs. 35.2 ± 17.9, respectively, p = 0.378); female gender was more prevalent in the ANEN group (65.7% vs. 38.3%, p = 0.017). ANEN size per pathology report was 17.0 ± 13.4 mm, and mesoappendix invasion was evident in 37.1%. Appendiceal diameter, regional lymph node number, and size were similar. Evidence of solid tissue in the appendiceal lumen per CT was more prevalent in the ANEN group compared to controls (7/20 [35%] vs. 2/30 [6.7%], p = 0.0008). Conclusions: Although the majority of ANEN cannot be identified in pre‐appendectomy imaging, 35% of cases demonstrate the presence of solid tissue in the appendiceal lumen. This finding may distinguish these patients from those with simple appendicitis and should lead to early surgical intervention, or close and more cautious surveillance if a conservative approach is chosen.
- Open Access
- 18 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12355
Interaction Between Early Meals (Big-Breakfast Diet), Clock Gene mRNA Expression, and Gut Microbiome to Regulate Weight Loss and Glucose Metabolism in Obesity and Type 2 Diabetes
The circadian clock gene system plays a pivotal role in coordinating the daily rhythms of most metabolic processes. It is synchronized with the light–dark cycle and the eating–fasting schedule. Notably, the interaction between meal timing and circadian clock genes (CGs) allows for optimizing metabolic processes at specific times of the day. Breakfast has a powerful resetting effect on the CG network. A misaligned meal pattern, such as skipping breakfast, can lead to a discordance between meal timing and the endogenous CGs, and is associated with obesity and T2D. Conversely, concentrating most calories and carbohydrates (CH) in the early hours of the day upregulates metabolic CG expression, thus promoting improved weight loss and glycemic control. Recently, it was revealed that microorganisms in the gastrointestinal tract, known as the gut microbiome (GM), and its derived metabolites display daily oscillation, and play a critical role in energy and glucose metabolism. The timing of meal intake coordinates the oscillation of GM and GM-derived metabolites, which in turn influences CG expression, playing a crucial role in the metabolic response to food intake. An imbalance in the gut microbiota (dysbiosis) can also reciprocally disrupt CG rhythms. Evidence suggests that misaligned meal timing may cause such disruptions and can lead to obesity and hyperglycemia. This manuscript focuses on the reciprocal interaction between meal timing, GM oscillation, and circadian CG rhythms. It will also review studies demonstrating how aligning meal timing with the circadian clock can reset and synchronize CG rhythms and GM oscillations. This synchronization can facilitate weight loss and improve glycemic control in obesity and those with T2D.
- 18 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12355
Open AccessInteraction Between Early Meals (Big-Breakfast Diet), Clock Gene mRNA Expression, and Gut Microbiome to Regulate Weight Loss and Glucose Metabolism in Obesity and Type 2 Diabetes
The circadian clock gene system plays a pivotal role in coordinating the daily rhythms of most metabolic processes. It is synchronized with the light–dark cycle and the eating–fasting schedule. Notably, the interaction between meal timing and circadian clock genes (CGs) allows for optimizing metabolic processes at specific times of the day. Breakfast has a powerful resetting effect on the CG network. A misaligned meal pattern, such as skipping breakfast, can lead to a discordance between meal timing and the endogenous CGs, and is associated with obesity and T2D. Conversely, concentrating most calories and carbohydrates (CH) in the early hours of the day upregulates metabolic CG expression, thus promoting improved weight loss and glycemic control. Recently, it was revealed that microorganisms in the gastrointestinal tract, known as the gut microbiome (GM), and its derived metabolites display daily oscillation, and play a critical role in energy and glucose metabolism. The timing of meal intake coordinates the oscillation of GM and GM-derived metabolites, which in turn influences CG expression, playing a crucial role in the metabolic response to food intake. An imbalance in the gut microbiota (dysbiosis) can also reciprocally disrupt CG rhythms. Evidence suggests that misaligned meal timing may cause such disruptions and can lead to obesity and hyperglycemia. This manuscript focuses on the reciprocal interaction between meal timing, GM oscillation, and circadian CG rhythms. It will also review studies demonstrating how aligning meal timing with the circadian clock can reset and synchronize CG rhythms and GM oscillations. This synchronization can facilitate weight loss and improve glycemic control in obesity and those with T2D.
- Open Access
- 12 April 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (8) , 7154
Influence of Fasting until Noon (Extended Postabsorptive State) on Clock Gene mRNA Expression and Regulation of Body Weight and Glucose Metabolism
The trend of fasting until noon (omission or delayed breakfast) is increasingly prevalent in modern society. This eating pattern triggers discordance between endogenous circadian clock rhythms and the feeding/fasting cycle and is associated with an increased incidence of obesity and T2D. Although the underlying mechanism of this association is not well understood, growing evidence suggests that fasting until noon, also known as an “extended postabsorptive state”, has the potential to cause a deleterious effect on clock gene expression and to disrupt regulation of body weight, postprandial and overall glycemia, skeletal muscle protein synthesis, and appetite, and may also lead to lower energy expenditure. This manuscript overviews the clock gene-controlled glucose metabolism during the active and resting phases and the consequences of postponing until noon the transition from postabsorptive to fed state on glucose metabolism, weight control, and energy expenditure. Finally, we will discuss the metabolic advantages of shifting more energy, carbohydrates (CH), and proteins to the early hours of the day.
- 12 April 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (8) , 7154
Open AccessInfluence of Fasting until Noon (Extended Postabsorptive State) on Clock Gene mRNA Expression and Regulation of Body Weight and Glucose Metabolism
The trend of fasting until noon (omission or delayed breakfast) is increasingly prevalent in modern society. This eating pattern triggers discordance between endogenous circadian clock rhythms and the feeding/fasting cycle and is associated with an increased incidence of obesity and T2D. Although the underlying mechanism of this association is not well understood, growing evidence suggests that fasting until noon, also known as an “extended postabsorptive state”, has the potential to cause a deleterious effect on clock gene expression and to disrupt regulation of body weight, postprandial and overall glycemia, skeletal muscle protein synthesis, and appetite, and may also lead to lower energy expenditure. This manuscript overviews the clock gene-controlled glucose metabolism during the active and resting phases and the consequences of postponing until noon the transition from postabsorptive to fed state on glucose metabolism, weight control, and energy expenditure. Finally, we will discuss the metabolic advantages of shifting more energy, carbohydrates (CH), and proteins to the early hours of the day.